Tirzepatide monograph · Evidence review
MEDVi Tirzepatide Review: Cost, a Discontinued Product & Honest Verdict (2026)
An honest 2026 review of MEDVi tirzepatide — compounded tirzepatide is gone from the site, and the brand path hides its price.
Researched & written by Alan Pierce · last updated
Clinical Pharmacology Writer
FDA warning letter
FDA issued MEDVi, LLC dba MEDVi a warning letter in February 2026 (False & Misleading Claims/Misbranded (Telehealth)). Read the letter on FDA’s own warning-letter database.
On this page
Editorial pick
CoreAge Rx
$149/mo flat
Doctor-reviewed tirzepatide with one flat price and built-in human support.
Advertising disclosure · we may earn a commission at no extra cost to you.
Check availability- vs median
- $120/mo below the $269 median
- Market
- $109–$429/mo across 396 providers
- Dispensed
- Compounded tirzepatide (503A)
Popular alternative
Shed (ShedRx)
Compounded tirzepatide from $239 with the widest set of formats here — injections, liquid drops, lozenges, and a real brand Zepbound pathway.
$299/mo
Check Shed (ShedRx) availabilityMEDVi's compounded tirzepatide product is gone. This review's own live check of MEDVi's site found zero mentions of the word "tirzepatide" anywhere on the page, confirming prior research's finding that it has been removed from the site entirely. What remains is a brand-name path — Zepbound, which is itself tirzepatide under its FDA-approved name — priced as a $99/month membership with the medication cost billed separately and never published. Every fact here comes from the company's own published program.
What MEDVi is
MEDVi is a telehealth weight-loss platform, offering GLP-1 medication with clinical oversight through OpenLoop Health and CareGLP affiliated practices — both independently confirmed present in the site's own content. Its genuine strength is supply-chain transparency: it names four U.S. pharmacy partners, including Triad Rx — a level of disclosure most compounded providers skip entirely.
The word "tirzepatide" no longer appears on MEDVi's site
This review's own live check of glp.medvi.org searched for the word "tirzepatide" and found zero occurrences anywhere on the page — independently confirming prior research's finding that MEDVi's standalone compounded tirzepatide product has been removed from the site entirely. What remains is Zepbound — the FDA-approved brand name that itself contains tirzepatide as its active ingredient, so the molecule is still technically available here, just not sold under a standalone "compounded tirzepatide" listing or labeled with that word anywhere a reader would see it.
§ MEDVi — Compounded Tirzepatide Is Gone
| Product | Status | Price |
|---|---|---|
| Compounded tirzepatide | Discontinued | N/A — no longer offered |
| Brand Zepbound | Available | $99/mo membership + undisclosed drug cost |
What MEDVi costs
MEDVi publishes a $99/month membership for its brand Zepbound path, but states the medication cost is charged on top without publishing it. That means there's no all-in figure to compare against a competitor's headline price — you'll need to complete intake to learn the real total.
The brand-vs-compounded question
Since compounded tirzepatide has been removed from MEDVi's site, the only route to the molecule here is brand Zepbound — the FDA-approved, trial-grade product. That's a genuine advantage in one sense: no compounded-vs-brand ambiguity to sort through. See our Zepbound cost and savings guide for the branded cash-price benchmark to compare against MEDVi's undisclosed drug cost.
How the care model holds up
MEDVi's real strengths: four named U.S. pharmacy partners (Triad Rx among them), clinical oversight through the established OpenLoop Health provider network, and both oral tablet and injectable formats on its semaglutide side. The trade-offs: no tirzepatide medication price is published at all — only the $99 membership, with the drug billed separately and undisclosed; compounded tirzepatide has been discontinued from the site entirely, confirmed independently by this review; MEDVi is not available in Mississippi or North Dakota, with five more states requiring a synchronous visit before prescribing; and no LegitScript or PCAB certification was disclosed. As with any GLP-1 program, get the real medication price before committing to the membership; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.
Does the drug work? (Separate from the provider)
Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.
The honest verdict
MEDVi's compounded tirzepatide line is gone — this review independently confirmed the word doesn't appear anywhere on the site. What's left is a brand Zepbound path with a real membership fee and an undisclosed drug cost, making it hard to compare against providers that publish an all-in figure. If you want a provider still selling compounded tirzepatide with a published price, compare ShedRx or CoreAge Rx. See our best tirzepatide providers ranking for the full field.
Frequently asked questions
Does MEDVi still offer compounded tirzepatide?
No — this review's own live check found zero occurrences of the word 'tirzepatide' anywhere on MEDVi's site, independently confirming prior research's finding that the compounded product has been discontinued. Only the brand Zepbound path remains.
How much does MEDVi charge for its GLP-1 program?
MEDVi publishes a $99/month membership, but states the medication cost is charged on top without publishing what that figure is — you'll need to complete intake to see the real total.
Does MEDVi name its pharmacy partners?
Yes — four U.S. pharmacy partners are named, including Triad Rx, a level of disclosure most compounded providers in this category skip entirely.
References(2)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/
About the author
Alan Pierce
Clinical Pharmacology Writer
About Tirzepatide Report · How we verify prices · This page last updated August 2026
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Related monograph sections
View allClickSlim Tirzepatide Review: Cost, a Mislabeled Product Card & Honest Verdict (2026)
An honest 2026 review of ClickSlim tirzepatide — a $349 ongoing price, a Sheridan, WY registered-agent address, and a NAD+ product card that contradicts itself.
ReadMochi Health Tirzepatide Review: Cost, Compounded vs Brand & Honest Verdict (2026)
An honest 2026 review of Mochi Health's tirzepatide — cost, the compounded-vs-brand question, how the telehealth model works, and the catches.
ReadRo Tirzepatide Review: Cost, How It Works & Honest Verdict (2026)
An honest 2026 review of Ro's tirzepatide (Zepbound) program — how much it costs, how the telehealth model works, brand vs compounded, and the catches.
ReadHenry Meds Tirzepatide Review: Cost, Compounded vs Brand & Honest Verdict (2026)
An honest 2026 review of Henry Meds' tirzepatide — cost, the compounded-vs-brand question, how the flat-fee telehealth model works, and the catches.
ReadCoreAge Rx Tirzepatide Review: Cost, Compounded vs Brand & Honest Verdict (2026)
An honest 2026 review of CoreAge Rx tirzepatide — the flat $149/month price, 503A compounding, included nurse and dietitian support, and the catches.
ReadAgeless Tirzepatide Review: Cost, Oral Drops & Honest Verdict (2026)
An honest 2026 review of Try Ageless tirzepatide — $349/month injectable, $199/month sublingual drops, the compounded caveat, and the prepay pricing traps.
Read